亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

Hyperoside金絲桃甙 CAS:482-36-0

 
 
單價 10.00 / 件對比
銷量 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
庫存 100000件起訂1件
品牌 成都云希
外觀 白色粉末
過期 長期有效
更新 2022-01-17 15:26
 

成都云希化工有限公司

企業(yè)會員第6年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

Products Name:Hyperoside

Cat NO.: BP0251

CAS NO.:482-36-0

Appearance: Yellow Powder

Formula:C21H20O12

Mol Weight:464.379

Botanical Source: A.venetum L.

Purity: 95%~99%

*pound Type: Flavonoids

Analysis Method: HPLC-DAD or/and HPLC-ELSD

Identification Method: Mass, NMR

Packing: Brown vial or HDPE plastic bottle

Storage: 2-8,Cool and dry place, Keep away from strong sunlight

Production Ability: Can be supplied from milligrams to grams and please inquire for bulk scale.

Remark: In case of quality issues, please contact us within 15days after received of products.

 

云希多肽,廠家直銷。

成都云希化工有限公司(ChengduYoungSheChemicalCo.,Ltd)成立于2015年,是一家新新有活力,不斷創(chuàng)新并且專門從事多肽化妝品原料研發(fā),生產(chǎn)和銷售的高新技術(shù)企業(yè)。公司總部位于成都市高新技術(shù)開發(fā)區(qū),月產(chǎn)量各種多肽10公斤以上,年銷售額逾千萬,客戶遍布多國。成都云希,以心交心,用心做肽,用心服務(wù)。經(jīng)過幾年的研究,成都云希現(xiàn)已開發(fā)出各種功效的美容肽上百種,基本囊括了市售的美容肽品種,主要有二勝肽(dipeptide),三勝肽(tripeptide),四勝肽(tetrapeptide),五勝肽(pentapeptide),六勝肽(hexapeptide),七勝肽(heptapeptide),八勝肽(octapptide),九勝肽(nonapeptide),十勝肽(decapeptide)和寡肽肽(Oligopeptide)等100多種美容肽,及多肽中間體、重組蛋白、藥物肽和其他化妝品活性原料如玻色因,種類齊全滿足客戶的需求。

咨詢或訂購請聯(lián)系陳女士

舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
云希專注勝肽乙酰基六肽-49/DELISENS 乙酰基六肽-1 乙酰基四肽-2 三肽-10瓜氨酸/核心蛋白聚糖肽 Polypeptide-23 乙酰基六肽-7抗衰多肽 Sh-Decapeptide-7 Oligopeptide-21/寡肽21
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |